Daniel J. Clauw

Sort by:

The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity.

Frederick Wolfe, Daniel J. Clauw, +7 authors Muhammad B. Yunus
Arthritis care & research
2010

OBJECTIVE To develop simple, practical criteria for clinical diagnosis of fibromyalgia that are suitable for use in primary and specialty care and that do not require a tender point examination, and… (More)

Fibromyalgia criteria and severity scales for clinical and epidemiological studies: a modification of the ACR Preliminary Diagnostic Criteria for Fibromyalgia.

Frederick Wolfe, Daniel J. Clauw, +7 authors John B. Winfield
The Journal of rheumatology
2011

OBJECTIVE To develop a fibromyalgia (FM) survey questionnaire for epidemiologic and clinical studies using a modification of the 2010 American College of Rheumatology Preliminary Diagnostic Criteria… (More)

Functional magnetic resonance imaging evidence of augmented pain processing in fibromyalgia.

Richard H. Gracely, Frank W Petzke, Julie M Wolf, Daniel J. Clauw
Arthritis and rheumatism
2002

OBJECTIVE To use functional magnetic resonance imaging (fMRI) to evaluate the pattern of cerebral activation during the application of painful pressure and determine whether this pattern is augmented… (More)

Evidence of Augmented Central Pain Processing in Idiopathic Chronic Low Back Pain

Thorsten Giesecke, Richard H. Gracely, +4 authors Daniel J. Clauw
Arthritis and rheumatism
2004

OBJECTIVE For many individuals with chronic low back pain (CLBP), there is no identifiable cause. In other idiopathic chronic pain conditions, sensory testing and functional magnetic resonance… (More)

Milnacipran for the treatment of fibromyalgia in adults: a 15-week, multicenter, randomized, double-blind, placebo-controlled, multiple-dose clinical trial.

Daniel J. Clauw, Philip J Mease, Robert W. H. Palmer, R. Michael Gendreau, Yong Wang
Clinical therapeutics
2008

BACKGROUND Preclinical and clinical studies have suggested that milnacipran, a dual norepinephrine-serotonin reuptake inhibitor, may be efficacious in the treatment of fibromyalgia (FM). OBJECTIVE… (More)

Decreased intrinsic brain connectivity is associated with reduced clinical pain in fibromyalgia.

Vitaly Napadow, Jieun E. Kim, Daniel J. Clauw, Richard E. Harris
Arthritis and rheumatism
2012

OBJECTIVE A major impediment to the development of novel treatment strategies for fibromyalgia (FM) is the lack of an objective marker that reflects spontaneously reported clinical pain in patients… (More)

Fibromyalgia: a clinical review.

Daniel J. Clauw
JAMA
2014

IMPORTANCE Fibromyalgia is present in as much as 2% to 8% of the population, is characterized by widespread pain, and is often accompanied by fatigue, memory problems, and sleep disturbances. … (More)

Fibromyalgia syndrome module at OMERACT 9: domain construct.

Philip J Mease, Lesley M. Arnold, +8 authors David A. Williams
The Journal of rheumatology
2009

The objective of the module was to (1) establish a core domain set for fibromyalgia (FM) assessment in clinical trials and practice, (2) review outcome measure performance characteristics, (3)… (More)

Fibromyalgia: an overview.

Daniel J. Clauw
The American journal of medicine
2009

Fibromyalgia is the diagnosis given to individuals with chronic widespread musculoskeletal pain for which no alternative cause, such as tissue inflammation or damage, can be identified. Fibromyalgia… (More)

Intrinsic brain connectivity in fibromyalgia is associated with chronic pain intensity.

Vitaly Napadow, Lauren LaCount, Kyungmo Park, Sawsan As-Sanie, Daniel J. Clauw, Richard E. Harris
Arthritis and rheumatism
2010

OBJECTIVE Fibromyalgia (FM) is considered to be the prototypical central chronic pain syndrome and is associated with widespread pain that fluctuates spontaneously. Multiple studies have demonstrated… (More)

Filter Results:

Publication Year

Publication Type

Co-author

Journals and Conferences